Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson Blood Flow in Type 1 Diabetes
NCT01019486Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in coronary artery disease (CAD), sponsored by University of Colorado Denver. Started Nov 2009; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01019486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019486.